CFTR modulators not linked to higher psychiatric symptom risk in CF
Study used multiple lines of investigation to evaluate several treatments Written by Michela Luciano, PhD CFTR modulators do not appear to increase the overall risk of depression, anxiety, or other neuropsychiatric symptoms in people with cystic fibrosis, a study has found. (Photo from iStock) CFTR modulators, a class of medications that boost the activity of a faulty CFTR protein in people with cystic fibrosis (CF), do not appear to increase the overall risk of depression, a








































